Adamus A, Melzacka M, Vetulani J
Pol J Pharmacol Pharm. 1984 Jan-Feb;36(1):51-8.
Tail-flick latencies and morphine concentrations in the blood serum, brain (without striatum) and spinal cord were measured in rats receiving 10 mg/kg ip morphine with or without haloperidol pretreatment (0.1 or 1 mg/kg sc). Haloperidol pretreatment dose-dependently potentiated the analgesic action of morphine and interfered with tissue morphine levels. Morphine levels in the spinal cord were similar to those in the blood serum and were dose-dependently increased by haloperidol pretreatment; in the brain the appearance of morphine was delayed, the levels lower than in the blood serum, and the effect of both doses of haloperidol (augmentation of morphine level) was similar. The results indicate that the analgesic effect of morphine in the tail-flick test is correlated better with the spinal than cerebral morphine levels and that potentiation of morphine analgesia by haloperidol is due, at least in part, to pharmacokinetic interaction.
对接受10mg/kg腹腔注射吗啡(无论是否预先皮下注射0.1或1mg/kg氟哌啶醇)的大鼠,测定其甩尾潜伏期以及血清、脑(不包括纹状体)和脊髓中的吗啡浓度。氟哌啶醇预处理剂量依赖性地增强了吗啡的镇痛作用,并干扰了组织中的吗啡水平。脊髓中的吗啡水平与血清中的相似,且氟哌啶醇预处理使其剂量依赖性增加;在脑中,吗啡的出现延迟,水平低于血清,且两种剂量的氟哌啶醇(增加吗啡水平)的作用相似。结果表明,在甩尾试验中,吗啡的镇痛效果与脊髓而非脑内的吗啡水平相关性更好,且氟哌啶醇增强吗啡镇痛作用至少部分归因于药代动力学相互作用。